ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Efavirenz Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-28W10309
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global and United States Efavirenz Market Report Forecast 2022 2028
BUY CHAPTERS

Global Efavirenz Market Research Report 2025

Code: QYRE-Auto-28W10309
Report
September 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb
TEVA
Mylan NV
Aurobindo Pharma
Cipla Ltd
Macleods Pharmaceuticals
Hetero

Efavirenz Market Size

The global market for Efavirenz was valued at US$ 137 million in the year 2024 and is projected to reach a revised size of US$ 186 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Efavirenz Market

Efavirenz Market

Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Efavirenz, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Efavirenz.
The Efavirenz market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Efavirenz market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Efavirenz manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Efavirenz Market Report

Report Metric Details
Report Name Efavirenz Market
Accounted market size in year US$ 137 million
Forecasted market size in 2031 US$ 186 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Two-drug combination
  • Three-drug combination
Segment by Application
  • Adults
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bristol-Myers Squibb, Teva, Mylan, Aurobindo Pharma, Cipla, Macleods Pharmaceuticals, Hetero
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Efavirenz manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Efavirenz in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Efavirenz Market growing?

Ans: The Efavirenz Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Efavirenz Market size in 2031?

Ans: The Efavirenz Market size in 2031 will be US$ 186 million.

Who are the main players in the Efavirenz Market report?

Ans: The main players in the Efavirenz Market are Bristol-Myers Squibb, Teva, Mylan, Aurobindo Pharma, Cipla, Macleods Pharmaceuticals, Hetero

What are the Application segmentation covered in the Efavirenz Market report?

Ans: The Applications covered in the Efavirenz Market report are Adults, Children

What are the Type segmentation covered in the Efavirenz Market report?

Ans: The Types covered in the Efavirenz Market report are Two-drug combination, Three-drug combination

Recommended Reports

Antiviral Drug Markets

API and Combination Drugs

Anti-Infectives and Related

1 Efavirenz Market Overview
1.1 Product Definition
1.2 Efavirenz by Type
1.2.1 Global Efavirenz Market Value Comparison by Type (2024 VS 2031)
1.2.2 Two-drug combination
1.2.3 Three-drug combination
1.3 Efavirenz by Application
1.3.1 Global Efavirenz Market Value by Application (2024 VS 2031)
1.3.2 Adults
1.3.3 Children
1.4 Global Efavirenz Market Size Estimates and Forecasts
1.4.1 Global Efavirenz Revenue 2020-2031
1.4.2 Global Efavirenz Sales 2020-2031
1.4.3 Global Efavirenz Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Efavirenz Market Competition by Manufacturers
2.1 Global Efavirenz Sales Market Share by Manufacturers (2020-2025)
2.2 Global Efavirenz Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Efavirenz Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Efavirenz, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Efavirenz, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Efavirenz, Product Type & Application
2.7 Global Key Manufacturers of Efavirenz, Date of Enter into This Industry
2.8 Global Efavirenz Market Competitive Situation and Trends
2.8.1 Global Efavirenz Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Efavirenz Players Market Share by Revenue
2.8.3 Global Efavirenz Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Efavirenz Market Scenario by Region
3.1 Global Efavirenz Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Efavirenz Sales by Region: 2020-2031
3.2.1 Global Efavirenz Sales by Region: 2020-2025
3.2.2 Global Efavirenz Sales by Region: 2026-2031
3.3 Global Efavirenz Revenue by Region: 2020-2031
3.3.1 Global Efavirenz Revenue by Region: 2020-2025
3.3.2 Global Efavirenz Revenue by Region: 2026-2031
3.4 North America Efavirenz Market Facts & Figures by Country
3.4.1 North America Efavirenz Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Efavirenz Sales by Country (2020-2031)
3.4.3 North America Efavirenz Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Efavirenz Market Facts & Figures by Country
3.5.1 Europe Efavirenz Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Efavirenz Sales by Country (2020-2031)
3.5.3 Europe Efavirenz Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Efavirenz Market Facts & Figures by Region
3.6.1 Asia Pacific Efavirenz Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Efavirenz Sales by Region (2020-2031)
3.6.3 Asia Pacific Efavirenz Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Efavirenz Market Facts & Figures by Country
3.7.1 Latin America Efavirenz Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Efavirenz Sales by Country (2020-2031)
3.7.3 Latin America Efavirenz Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Efavirenz Market Facts & Figures by Country
3.8.1 Middle East and Africa Efavirenz Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Efavirenz Sales by Country (2020-2031)
3.8.3 Middle East and Africa Efavirenz Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Efavirenz Sales by Type (2020-2031)
4.1.1 Global Efavirenz Sales by Type (2020-2025)
4.1.2 Global Efavirenz Sales by Type (2026-2031)
4.1.3 Global Efavirenz Sales Market Share by Type (2020-2031)
4.2 Global Efavirenz Revenue by Type (2020-2031)
4.2.1 Global Efavirenz Revenue by Type (2020-2025)
4.2.2 Global Efavirenz Revenue by Type (2026-2031)
4.2.3 Global Efavirenz Revenue Market Share by Type (2020-2031)
4.3 Global Efavirenz Price by Type (2020-2031)
5 Segment by Application
5.1 Global Efavirenz Sales by Application (2020-2031)
5.1.1 Global Efavirenz Sales by Application (2020-2025)
5.1.2 Global Efavirenz Sales by Application (2026-2031)
5.1.3 Global Efavirenz Sales Market Share by Application (2020-2031)
5.2 Global Efavirenz Revenue by Application (2020-2031)
5.2.1 Global Efavirenz Revenue by Application (2020-2025)
5.2.2 Global Efavirenz Revenue by Application (2026-2031)
5.2.3 Global Efavirenz Revenue Market Share by Application (2020-2031)
5.3 Global Efavirenz Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Company Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Efavirenz Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bristol-Myers Squibb Efavirenz Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Efavirenz Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Efavirenz Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Efavirenz Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mylan Efavirenz Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Company Information
6.4.2 Aurobindo Pharma Description and Business Overview
6.4.3 Aurobindo Pharma Efavirenz Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Aurobindo Pharma Efavirenz Product Portfolio
6.4.5 Aurobindo Pharma Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Efavirenz Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cipla Efavirenz Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Macleods Pharmaceuticals
6.6.1 Macleods Pharmaceuticals Company Information
6.6.2 Macleods Pharmaceuticals Description and Business Overview
6.6.3 Macleods Pharmaceuticals Efavirenz Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Macleods Pharmaceuticals Efavirenz Product Portfolio
6.6.5 Macleods Pharmaceuticals Recent Developments/Updates
6.7 Hetero
6.7.1 Hetero Company Information
6.7.2 Hetero Description and Business Overview
6.7.3 Hetero Efavirenz Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hetero Efavirenz Product Portfolio
6.7.5 Hetero Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Efavirenz Industry Chain Analysis
7.2 Efavirenz Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Efavirenz Production Mode & Process Analysis
7.4 Efavirenz Sales and Marketing
7.4.1 Efavirenz Sales Channels
7.4.2 Efavirenz Distributors
7.5 Efavirenz Customer Analysis
8 Efavirenz Market Dynamics
8.1 Efavirenz Industry Trends
8.2 Efavirenz Market Drivers
8.3 Efavirenz Market Challenges
8.4 Efavirenz Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bristol–Myers Squibb
TEVA
Mylan NV
Aurobindo Pharma
Cipla Ltd
Macleods Pharmaceuticals
Hetero
List of Tables
 Table 1. Global Efavirenz Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Efavirenz Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Efavirenz Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Efavirenz Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Efavirenz Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Efavirenz Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Efavirenz Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Efavirenz Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Efavirenz, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Efavirenz, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Efavirenz, Product Type & Application
 Table 12. Global Key Manufacturers of Efavirenz, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Efavirenz by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Efavirenz as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Efavirenz Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Efavirenz Sales by Region (2020-2025) & (K Units)
 Table 18. Global Efavirenz Sales Market Share by Region (2020-2025)
 Table 19. Global Efavirenz Sales by Region (2026-2031) & (K Units)
 Table 20. Global Efavirenz Sales Market Share by Region (2026-2031)
 Table 21. Global Efavirenz Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Efavirenz Revenue Market Share by Region (2020-2025)
 Table 23. Global Efavirenz Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Efavirenz Revenue Market Share by Region (2026-2031)
 Table 25. North America Efavirenz Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Efavirenz Sales by Country (2020-2025) & (K Units)
 Table 27. North America Efavirenz Sales by Country (2026-2031) & (K Units)
 Table 28. North America Efavirenz Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Efavirenz Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Efavirenz Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Efavirenz Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Efavirenz Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Efavirenz Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Efavirenz Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Efavirenz Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Efavirenz Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Efavirenz Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Efavirenz Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Efavirenz Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Efavirenz Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Efavirenz Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Efavirenz Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Efavirenz Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Efavirenz Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Efavirenz Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Efavirenz Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Efavirenz Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Efavirenz Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Efavirenz Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Efavirenz Sales (K Units) by Type (2020-2025)
 Table 51. Global Efavirenz Sales (K Units) by Type (2026-2031)
 Table 52. Global Efavirenz Sales Market Share by Type (2020-2025)
 Table 53. Global Efavirenz Sales Market Share by Type (2026-2031)
 Table 54. Global Efavirenz Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Efavirenz Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Efavirenz Revenue Market Share by Type (2020-2025)
 Table 57. Global Efavirenz Revenue Market Share by Type (2026-2031)
 Table 58. Global Efavirenz Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Efavirenz Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Efavirenz Sales (K Units) by Application (2020-2025)
 Table 61. Global Efavirenz Sales (K Units) by Application (2026-2031)
 Table 62. Global Efavirenz Sales Market Share by Application (2020-2025)
 Table 63. Global Efavirenz Sales Market Share by Application (2026-2031)
 Table 64. Global Efavirenz Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Efavirenz Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Efavirenz Revenue Market Share by Application (2020-2025)
 Table 67. Global Efavirenz Revenue Market Share by Application (2026-2031)
 Table 68. Global Efavirenz Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Efavirenz Price (USD/Unit) by Application (2026-2031)
 Table 70. Bristol-Myers Squibb Company Information
 Table 71. Bristol-Myers Squibb Description and Business Overview
 Table 72. Bristol-Myers Squibb Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Bristol-Myers Squibb Efavirenz Product
 Table 74. Bristol-Myers Squibb Recent Developments/Updates
 Table 75. Teva Company Information
 Table 76. Teva Description and Business Overview
 Table 77. Teva Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Teva Efavirenz Product
 Table 79. Teva Recent Developments/Updates
 Table 80. Mylan Company Information
 Table 81. Mylan Description and Business Overview
 Table 82. Mylan Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Mylan Efavirenz Product
 Table 84. Mylan Recent Developments/Updates
 Table 85. Aurobindo Pharma Company Information
 Table 86. Aurobindo Pharma Description and Business Overview
 Table 87. Aurobindo Pharma Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Aurobindo Pharma Efavirenz Product
 Table 89. Aurobindo Pharma Recent Developments/Updates
 Table 90. Cipla Company Information
 Table 91. Cipla Description and Business Overview
 Table 92. Cipla Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Cipla Efavirenz Product
 Table 94. Cipla Recent Developments/Updates
 Table 95. Macleods Pharmaceuticals Company Information
 Table 96. Macleods Pharmaceuticals Description and Business Overview
 Table 97. Macleods Pharmaceuticals Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Macleods Pharmaceuticals Efavirenz Product
 Table 99. Macleods Pharmaceuticals Recent Developments/Updates
 Table 100. Hetero Company Information
 Table 101. Hetero Description and Business Overview
 Table 102. Hetero Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Hetero Efavirenz Product
 Table 104. Hetero Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Efavirenz Distributors List
 Table 108. Efavirenz Customers List
 Table 109. Efavirenz Market Trends
 Table 110. Efavirenz Market Drivers
 Table 111. Efavirenz Market Challenges
 Table 112. Efavirenz Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Efavirenz
 Figure 2. Global Efavirenz Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Efavirenz Market Share by Type: 2024 & 2031
 Figure 4. Two-drug combination Product Picture
 Figure 5. Three-drug combination Product Picture
 Figure 6. Global Efavirenz Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Efavirenz Market Share by Application: 2024 & 2031
 Figure 8. Adults
 Figure 9. Children
 Figure 10. Global Efavirenz Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Efavirenz Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Efavirenz Sales (2020-2031) & (K Units)
 Figure 13. Global Efavirenz Average Price (USD/Unit) & (2020-2031)
 Figure 14. Efavirenz Report Years Considered
 Figure 15. Efavirenz Sales Share by Manufacturers in 2024
 Figure 16. Global Efavirenz Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Efavirenz Players: Market Share by Revenue in Efavirenz in 2024
 Figure 18. Efavirenz Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Efavirenz Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Efavirenz Sales Market Share by Country (2020-2031)
 Figure 21. North America Efavirenz Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Efavirenz Sales Market Share by Country (2020-2031)
 Figure 25. Europe Efavirenz Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Efavirenz Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Efavirenz Revenue Market Share by Region (2020-2031)
 Figure 33. China Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Efavirenz Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Efavirenz Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Efavirenz Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Efavirenz Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Efavirenz Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Efavirenz by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Efavirenz by Type (2020-2031)
 Figure 55. Global Efavirenz Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Efavirenz by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Efavirenz by Application (2020-2031)
 Figure 58. Global Efavirenz Price (USD/Unit) by Application (2020-2031)
 Figure 59. Efavirenz Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Efavirenz API Market Research Report 2025
Global Enfuvirtide for Injection Market Research Report 2024
Global Darunavir Market Insights Forecast to 2030
Stavudine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nelfinavir Market Research Report 2024
Global Zidovudine Market Insights Forecast to 2030
Global Tenofovir Fumarate Market Research Report 2024
Global Efavirenz Tenofovir Emtricitabine Combination Drug Market Research Report 2024
Global Efavirenz Lamivudine Tenofovir Compound Drugs Market Research Report 2024
Global Oseltamivir Market Insights Forecast to 2030
Global Raltegravir API Market Research Report 2025
HIV Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Zidovudine API Market Research Report 2025
Global Long acting Anti HIV Drugs Market Research Report 2024
Global Favipiravir Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Solifenacin Succinate Drug Market Insights Forecast to 2030
Global Indinavir Sulfate Market Research Report 2024
Flecainide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HIV Therapy Market Research Report 2025
Global Tamiflu Oseltamivir Phosphate Market Insights Forecast to 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions